Skip to main content

Corporate insider profile

Gilead Raday Insider Trades

Latest reported as Chief Operating Officer of RedHill Biopharma Ltd. (RDHL).

Purchase filings
0
Reported companies
1
Net open-market value
-$4,418.00
Latest transaction
Oct 1, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 1, 2026RedHill Biopharma Ltd. (RDHL)Chief Operating OfficerSale14,310,000$0.00$1,431
Jul 10, 2026RedHill Biopharma Ltd. (RDHL)Chief Operating OfficerSale14,130,000$0.00$1,413
Apr 6, 2026RedHill Biopharma Ltd. (RDHL)Chief Operating OfficerSale15,740,000$0.00$1,574